ERBB4 and lung adenocarcinoma: The knockdown of Her-2, Her-3, or Her-4 was incapable of affecting EGFR-related signaling as EGFR knockdown in the EGFR-nonaddictive lung adenocarcinoma cells (Figure 4F).